Search | IOVS | ARVO Journals

Showing 1 – 20 of 39

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Incidence of Cataract in Eyes with Anterior Uveitis

John H Kempen; George N. Papaliodis; Bernard Rosner; Kurt Dreger; Gui-Shuang Ying; C Stephen Foster; Douglas A Jabs; James Rosenbaum; Grace A Levy-Clarke; H Nida Sen; Eric B Suhler; Jennifer E Thorne; Nirali Bhatt

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2069. doi:

ARVO Annual Meeting Abstract June 2020

Incidence and Risk of Cataract Formation in Intermediate Uveitis

Caroline Minkus; Maxwell Pistilli; Kurt Dreger; Tonetta Fitzgerald; Abhishek Payal; Hosne Begum; R Oktay Kacmaz; Douglas A Jabs; James Rosenbaum; Grace A Levy-Clarke; H Nida Sen; Eric B Suhler; Jennifer E Thorne; Nirali Bhatt; C Stephen Foster; John H Kempen

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2070. doi:

ARVO Annual Meeting Abstract July 2019

Factors Predictive of Remission of Chronic Anterior Uveitis

Lucia Sobrin; Maxwell Pistilli; Srishti Kothari; Naira Khachatryan; Pichaporn Artornsombudh; Siddharth Pujari; Charles Stephen Foster; Douglas A Jabs; James T Rosenbaum; Grace Levy-Clarke; H Nida Sen; Eric B Suhler; Jennifer E Thorne; Nirali P Bhatt; John H Kempen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6683. doi:

ARVO Annual Meeting Abstract July 2019

Dexamethasone Intravitreal Implantation To Treat Uveitic Macular Edema

Grace Levy-Clarke; Jeffrey Wipfli; Nandesh N. Patel; Mireya Benitez Cartaya; John H Kempen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3512. doi:

ARVO Annual Meeting Abstract July 2019

Risk of Overall and Cancer Mortality After Immunosuppression of Patients with Non-infectious Ocular Inflammatory Diseases.

John H Kempen; Craig W Newcomb; Charles S Foster; Douglas A Jabs; Grace Levy-Clarke; James T Rosenbaum; H Nida Sen; Eric B Suhler; Jennifer E Thorne; Nirali P Bhatt; Jeanine M Buchanich

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3854. doi:

ARVO Annual Meeting Abstract June 2013

The Prevalence, Incidence and Risk Factors for Exudative Retinal Detachment in Uveitis

Deepika Shah; Craig Newcomb; Grace Levy-Clarke; Robert Nussenblatt; James Rosenbaum; Eric Suhler; Jennifer Thorne; C. Stephen Foster; Douglas Jabs; John Kempen

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):2939. doi:

ARVO Annual Meeting Abstract March 2012

Remission Of Intermediate Uveitis: Rate And Predictive Factors

Dina Gewaily; Craig Newcomb; Grace Levy-Clarke; Robert B. Nussenblatt; James T. Rosenbaum; Eric B. Suhler; Jennifer E. Thorne; C Stephen Foster; Douglas A. Jabs; John H. Kempen

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5478. doi:

ARVO Annual Meeting Abstract March 2012

Visual Acuity in Patients with Non-Infectious Uveitis: Outcome Over Time and Risk Factors

Maxwell Pistilli; Marshall M. Joffe; Douglas A. Jabs; Grace A. Levy-Clarke; Robert B. Nussenblatt; James T. Rosenbaum; Eric B. Suhler; Jennifer E. Thorne; C Stephen Foster; John H. Kempen

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4165. doi:

ARVO Annual Meeting Abstract March 2012

Methotrexate vs. Mycophenolate Mofetil for Ocular Inflammatory Diseases

John H. Kempen; Craig W. Newcomb; Robert B. Nussenblatt; James T. Rosenbaum; Eric B. Suhler; Jennifer E. Thorne; C Stephen Foster; Douglas A. Jabs; Grace A. Levy-Clarke; Marshall M. Joffe

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4169. doi:

ARVO Annual Meeting Abstract March 2012

Adalimumab for Ocular Inflammation

Khayyam Durrani; John H. Kempen; Gui-Shuang Ying; James T. Rosenbaum; Eric B. Suhler; Jennifer E. Thorne; Douglas A. Jabs; Grace A. Levy-Clarke; Robert B. Nussenblatt; C. Stephen Foster

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5492. doi:

ARVO Annual Meeting Abstract March 2012

Risk Factors for Loss of Visual Acuity among Patients with Uveitis Associated With Juvenile Idiopathic Arthritis: The SITE Study

Jennifer E. Thorne; Anthony Gregory; Ebenezer Daniel; C Stephen Foster; Douglas A. Jabs; Grace A. Levy-Clarke; Robert B. Nussenblatt; James T. Rosenbaum; Eric B. Suhler; John H. Kempen

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6253. doi:

Immunology and Microbiology August 2011

Suppressor of Cytokine Signaling-1 (SOCS1) Inhibits Lymphocyte Recruitment into the Retina and Protects SOCS1 Transgenic Rats and Mice from Ocular Inflammation

PDF

Cheng-Rong Yu; Rashid R. Mahdi; Hyun-Mee Oh; Ahjoku Amadi-Obi; Grace Levy-Clarke; Jenna Burton; Amarachi Eseonu; YongJun Lee; Chi-Chao Chan; Charles E. Egwuagu
TAGS: animals, transgenic, cytokine, mice, rats, retina, socs1 gene, uveitis, eye inflammation, signal transduction, lymphocytes
Invest. Ophthalmol. Vis. Sci.. 2011; 52(9):6978-6986. doi: https://doi.org/10.1167/iovs.11-7688

ARVO Annual Meeting Abstract April 2011

Risk Of Clinically Manifest Hyperglycemia Among Patients Receiving Systemic Corticosteroids For Inflammatory Eye Disease

Joshua D. Udoetuk; Yang Dai; James T. Rosenbaum; Eric B. Suhler; Jennifer E. Thorne; C Stephen Foster; Douglas A. Jabs; Grace A. Levy-Clarke; Robert B. Nussenblatt; John H. Kempen

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2748. doi:

ARVO Annual Meeting Abstract April 2011

Risk Factors For Retinal Neovascularization In Patients With Uveitis

Apurva K. Patel; Craig W. Newcomb; Eric B. Suhler; Jennifer E. Thorne; C Stephen Foster; Douglas A. Jabs; Grace A. Levy-Clarke; Robert B. Nussenblatt; James T. Rosenbaum; John H. Kempen

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):2756. doi:

ARVO Annual Meeting Abstract April 2011

Incidence and Risk factors for Hypotony in Uveitis

Ebenezer Daniel; Maxwell Pistilli; Robert B. Nussenblatt; James T. Rosenbaum; Eric B. Suhler; Jennifer E. Thorne; C Stephen Foster; Douglas A. Jabs; Grace A. Levy-Clarke; John H. Kempen

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4308. doi:

ARVO Annual Meeting Abstract April 2010

Intravenous Pulsed Corticosteroids for Ocular Inflammatory Diseases

L. D. Charkoudian; G.-S. Ying; J. E. Thorne; C. Foster; D. A. Jabs; G. A. Levy-Clarke; R. B. Nussenblatt; J. T. Rosenbaum; E. B. Suhler; J. H. Kempen

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5257. doi:

ARVO Annual Meeting Abstract April 2010

Adverse Effects of Smoking on Patients with Ocular Inflammation

A. Galor; W. Feuer; J. H. Kempen; E. B. Suhler; C. Foster; D. A. Jabs; G. A. Levy-Clarke; R. B. Nussenblatt; J. T. Rosenbaum; J. E. Thorne

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):6379. doi:

ARVO Annual Meeting Abstract April 2009

Treatment of Active Anterior Uveitis Associated With JIA Using Daclizumab

H. Sen; G. Levy-Clarke; L. J. Faia; L. Zhuqing; K. S. Barron; K. Hammel; R. B. Nussenblatt

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2682. doi:

ARVO Annual Meeting Abstract April 2009

Cyclophosphamide for Ocular Inflammatory Diseases

S. Pujari; J. H. Kempen; C. W. Newcomb; E. B. Suhler; J. E. Thorne; D. A. Jabs; G. A. Levy-Clarke; R. B. Nussenblatt; J. T. Rosenbaum; C. S. Foster

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2020. doi:

ARVO Annual Meeting Abstract April 2009

Methotrexate for Ocular Inflammatory Diseases

G. A. Levy-Clarke; S. Gangaputra; C. W. Newcomb; D. A. Jabs; R. B. Nussenblatt; J. T. Rosenbaum; E. B. Suhler; J. E. Thorne; C. S. Foster; J. H. Kempen

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2023. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Incidence of Cataract in Eyes with Anterior Uveitis

Incidence and Risk of Cataract Formation in Intermediate Uveitis

Factors Predictive of Remission of Chronic Anterior Uveitis

Dexamethasone Intravitreal Implantation To Treat Uveitic Macular Edema

Risk of Overall and Cancer Mortality After Immunosuppression of Patients with Non-infectious Ocular Inflammatory Diseases.

The Prevalence, Incidence and Risk Factors for Exudative Retinal Detachment in Uveitis

Remission Of Intermediate Uveitis: Rate And Predictive Factors

Visual Acuity in Patients with Non-Infectious Uveitis: Outcome Over Time and Risk Factors

Methotrexate vs. Mycophenolate Mofetil for Ocular Inflammatory Diseases

Adalimumab for Ocular Inflammation

Risk Factors for Loss of Visual Acuity among Patients with Uveitis Associated With Juvenile Idiopathic Arthritis: The SITE Study

Suppressor of Cytokine Signaling-1 (SOCS1) Inhibits Lymphocyte Recruitment into the Retina and Protects SOCS1 Transgenic Rats and Mice from Ocular Inflammation

Risk Of Clinically Manifest Hyperglycemia Among Patients Receiving Systemic Corticosteroids For Inflammatory Eye Disease

Risk Factors For Retinal Neovascularization In Patients With Uveitis

Incidence and Risk factors for Hypotony in Uveitis

Intravenous Pulsed Corticosteroids for Ocular Inflammatory Diseases

Adverse Effects of Smoking on Patients with Ocular Inflammation

Treatment of Active Anterior Uveitis Associated With JIA Using Daclizumab

Cyclophosphamide for Ocular Inflammatory Diseases

Methotrexate for Ocular Inflammatory Diseases

To View More...

You must be signed into an individual account to use this feature.